Back to Search
HOWARD SAFRAN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1982616744IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD08407(RI)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1987
Research & Publications (20)
Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity.
PMID 17980508·Int J Radiat Oncol Biol Phys·2008
3-trial
Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin: a phase I study for advanced pancreaticobiliary cancer.
PMID 18391597·Am J Clin Oncol·2008
3-trial
Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma.
PMID 17097832·Int J Radiat Oncol Biol Phys·2007
3-trial
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
PMID 15581051·Cancer Invest·2004
3-trial
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I study.
PMID 15581047·Cancer Invest·2004
3-trial
Paclitaxel as a radiation sensitizer for locally advanced pancreatic cancer.
PMID 12098607·Crit Rev Oncol Hematol·2002
6-review
Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial.
PMID 12182983·Int J Radiat Oncol Biol Phys·2002
3-trial
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer.
PMID 11291548·Cancer Invest·2001
3-trial
Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
PMID 11586103·Am J Clin Oncol·2001
8-other
Paclitaxel and concurrent radiation for locally advanced pancreatic cancer.
PMID 11286834·Int J Radiat Oncol Biol Phys·2001
3-trial
Paclitaxel and concurrent radiation for gastric cancer.
PMID 10705010·Int J Radiat Oncol Biol Phys·2000
3-trial
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
PMID 19636002·J Clin Oncol·2009
3-trial
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors.
PMID 19118068·Clin Cancer Res·2009
3-trial
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
PMID 18319412·JAMA·2008
3-trial
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704.
PMID 19029412·J Clin Oncol·2008
3-trial
A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer.
PMID 17762433·Am J Clin Oncol·2007
3-trial
HER family inhibitors in pancreatic cancer: current status and future directions.
PMID 17298292·Expert Opin Ther Targets·2007
6-review
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
PMID 17392258·Radiology·2007
8-other
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
PMID 17882656·Cancer Invest·2007
3-trial
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study.
PMID 16891865·Am J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 164 SUMMIT AVE, 3RD FLOOR FAIN BUILDING
PROVIDENCE, RI 02906 - Phone
- (401) 793-2920
Quick Facts
- NPI
- 1982616744
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile